Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2012
12/11/2012US8329462 Methods and compositions relating to improved lentiviral vectors and their applications
12/11/2012US8329442 Salmonella bacteriophage and antibacterial composition comprising the same
12/11/2012US8329165 Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
12/11/2012US8329164 Methods and compositions concerning poxviruses and cancer
12/11/2012CA2481479C Novel flavivirus antigens
12/06/2012WO2012167144A1 Nanocoatings for biological materials
12/06/2012WO2012167139A2 Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines
12/06/2012WO2012165542A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
12/06/2012WO2012164413A2 Wdr13 as a novel biomarker useful for treating diabetes and cancer
12/06/2012WO2012164130A1 Deficient cell construct in a negative influenza virus modulator for increasing vaccine virus production
12/06/2012WO2012142529A3 Clonal strains of attenuated vaccinia viruses and methods of use thereof
12/06/2012US20120309056 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
12/06/2012US20120309032 Animal Model Having a Chimeric Human Liver and Suceptible to Human Hepatitis C Virus Infection
12/06/2012US20120308995 Vaccinia virus mutants containing the major genomic deletions of mva
12/06/2012US20120308602 Recombinant RSV Virus Expression Systems And Vaccines
12/06/2012US20120308601 Methods and materials for treating cancer
12/06/2012US20120308594 Hcv clade and prototype sequences thereof
12/06/2012US20120308484 Clonal strains of attenuated vaccinia viruses and methods of use thereof
12/06/2012CA2837279A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
12/05/2012EP2530161A2 Process for producing poxviruses and poxvirus compositions
12/05/2012EP2530147A2 Influenza hemagglutinin and neuraminidase variants
12/05/2012EP2530086A1 Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
12/05/2012EP2529020A1 A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
12/05/2012EP2529010A1 Vaccinia virus mutants containing the major genomic deletions of mva
12/05/2012CN102807992A Method for structuring CAV (Chicken Anemia Virus) infectious molecular clone
12/05/2012CN102807989A Preparation method of recombination live vector vaccines for diseases of canid and/or feline
12/05/2012CN102807972A Hepatitis A virus purification method
12/05/2012CN102807970A Canine distemper virus (CDV) sensitive cell line and establishment method and application thereof
12/05/2012CN102807969A Transgenic insect cell line for high-yield baculovirus, and preparation method and application thereof
12/05/2012CN102807968A Transgenic fat body cell line of high-yield baculovirus and preparation method as well as application thereof
12/05/2012CN102805863A Preparation method of novel bunyavirus purification inactivated vaccine by culturing human diploid cell
12/05/2012CN102206614B Novel method for preparing mixed glue solution for purifying virus plaques and cloning viruses
12/04/2012US8323959 Microorganisms for therapy
12/04/2012US8323658 Infectious bursal disease virus antigenic isolates and vaccines
12/04/2012CA2371714C Streptococcus pneumoniae proteins and vaccines
11/2012
11/29/2012WO2012162137A1 Hepatitis c virus particles, vaccines, compositions and methods related thereto
11/29/2012WO2012159774A1 Novel listeria bacteriophage p825n and uses thereof
11/29/2012WO2012159562A1 Truncated human papillomavirus type 33 protein l1
11/29/2012WO2012159522A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/29/2012US20120301503 Influenza hemagglutinin and neuraminidase variants
11/29/2012US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use
11/29/2012US20120301462 Compounds
11/29/2012US20120301461 1d05 pcsk9 antagonists
11/29/2012US20120301433 Bacteriophages expressing amyloid peptides and uses thereof
11/29/2012CA2837126A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/28/2012EP2526966A2 Herpes simplex virus combined subunit vaccines and methods of use thereof
11/28/2012CN102803478A Improved Methods For Purification Of Recombinant Aav Vectors
11/28/2012CN102803477A New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
11/28/2012CN102802666A Swine Influenza Hemagglutinin Variants
11/28/2012CN102796749A Epidemic encephalitis B/dengue chimeric virus with epidemic encephalitis B virus attenuated strain as gene framework and application of epidemic encephalitis B/dengue chimeric virus
11/28/2012CN102796710A Non-pathogenic recombinant attenuated rabies virus strain and construction method and application thereof
11/28/2012CN102796709A Liver cancer-specific gene-virus and application thereof
11/28/2012CN102796708A Method for proliferating influenza A viruses
11/28/2012CN102796183A Insecticidal protein, and coding gene and purposes thereof
11/28/2012CN102796182A Insecticidal protein, as well as coding gene and application thereof
11/28/2012CN102793917A Porcine encephalitis B vaccine and preparation method thereof
11/28/2012CN101253261B Diagnostic test kits
11/27/2012US8318480 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012CA2461579C Porcine adenovirus e1 region
11/27/2012CA2413151C Host cells containing multiple integrating vectors
11/22/2012WO2012156933A1 Combination of oncolytic adenoviruses with histone deacetylase inhibitors
11/22/2012WO2012155262A1 Virus-like particles and process for preparing same
11/22/2012WO2012155261A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
11/22/2012WO2012129873A3 Method for preparing antitumor biological product
11/22/2012WO2012115474A3 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same
11/22/2012US20120295813 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages
11/22/2012US20120294892 Avirulent Salmonella Gallinarum Variants and Pharmaceutical Composition Using the Same
11/22/2012US20120294890 Recombinant Parainfluenza Virus Expression Systems And Vaccines
11/22/2012US20120294889 Chimeric Flavivirus Vaccines
11/22/2012CA2835972A1 Virus-like particles and process for preparing same
11/22/2012CA2835967A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
11/21/2012EP2523681A1 Methods of producing adenovirus vectors and viral preparations generated thereby
11/21/2012CN102791852A Method for the purification of adenovirus particles
11/21/2012CN102791288A Recombinant attenuated parvovirus
11/21/2012CN102787119A Products and methods for treatment and/or prevention of virus infections
11/21/2012CN102787102A Porcine alpha interferon mature-protein recombinant adenovirus, construction method and application thereof
11/21/2012CN102787101A 24-dehydrocholesterol reductase coded recombinant adenoviruses specifically expressed in tissue
11/21/2012CN102787100A High-prolificacy porcine circovirus type-2 strain and application thereof
11/21/2012CN102787099A Chick embryo culture method for White spot syndrome virus
11/21/2012CN102786585A Insecticidal protein, coding gene of insecticidal protein and purpose of insecticidal protein
11/21/2012CN102786584A Insecticidal protein, coding gene of insecticidal protein and purpose of insecticidal protein
11/21/2012CN102784390A Method for preparing thermal-stability vaccine
11/21/2012CN102268412B Hepatitis C virus (HCV) nonstructural protein/GB virus B (GBV-B) hybrid virus
11/21/2012CN102174477B Hepatitis A virus strain SH and diploid cell adaptation method thereof
11/21/2012CN102174476B Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof
11/21/2012CN101914139B Human papilloma virus (HPV) capsid protein L1 polypeptide and preparation and application thereof
11/21/2012CN101580849B Dna-transfection system for generation of infectious influenza virus
11/20/2012CA2762042C Chimeric influenza virus-like particles comprising hemagglutinin
11/20/2012CA2343653C Recombinant newcastle disease virus rna expression systems and vaccines
11/15/2012WO2012154994A2 A novel adenovirus isolated from titi monkeys
11/15/2012WO2012069190A3 Depletion of host cell components from live virus vaccines
11/15/2012US20120288916 Immortalized avian cell lines for virus production
11/15/2012US20120288522 Novel Pneumovirus Compositions and Methods For Using the Same
11/15/2012US20120288521 Multi plasmid system for the production of influenza virus
11/15/2012US20120288520 Recombinant Flavivirus Vaccines
11/14/2012EP2522719A1 Influenza hemagglutinin and neuraminidase variants
11/14/2012CN102776198A Method for expressing recombinant human bone morphogenetic protein in insect cell
11/14/2012CN102776179A Wheat dwarf gene tandem repeat fragment and application thereof
11/14/2012CN102776156A Gene VIb subtype Rubulavirus Newcastle disease virus attenuated strain VIbI4 and construction method thereof
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 267